Printer Friendly

Zacks Bull and Bear of the Day Highlights: AtheroGenics, ProQuest Company, Bayer A.G. and Yahoo!

CHICAGO -- Zacks Equity Research highlights AtheroGenics, Inc. (Nasdaq:AGIX) as the Bull of the Day and ProQuest Company (NYSE:PQE) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Bayer A.G. (NYSE:BAY) and Yahoo! (Nasdaq:YHOO). Full analysis of all four stocks is available at http://at.zacks.com/?id=2676.

Here is a synopsis of all four stocks:

Bull of the Day:

Our Bull of the Day recommendation is for AtheroGenics, Inc. (Nasdaq:AGIX), a biotechnology company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. The company uses its proprietary vascular protectant (V-Protectant) technology platform to develop drug candidates. The leading pipeline candidate is AGI-1067 for atherosclerosis. We believe this candidate has billion-dollar blockbuster potential. The shares are attractive given the potential upside ahead. We recommend long-term investors buy the shares.

Bear of the Day:

Our Bear of the Day recommendation is for ProQuest Company (NYSE:PQE). ProQuest expects its accounting review will result in the restatement of earnings reported for fiscal years 2000 to 2004 and for the first three quarters of 2005. The company also provided 2006 revenue and EBIT guidance. Consequently, we have downgraded the stock from a Hold to a Sell, and the target price has been set to $10.

Analyst Blog:

Driven by sales gains and enhanced operating leverage, Bayer (NYSE:BAY) continues to post impressive results across all its operating segments. The company is investing significantly on research and development in the pharmaceutical and chemical business. Further, the acquisition of Schering AG will strengthen the company's position in the HealthCare business. Moreover, an upturn in the petrochemical cycle and improved chemical pricing power are expected to propel growth further, making the stock fairly attractive to investors. Accordingly, we reiterate our Buy rating, with a target price of $54.50.

We believe as a leader in branded advertising, Yahoo! (Nasdaq:YHOO) will be a prime beneficiary of the shift in advertising spending from traditional media to online media. Yahoo has established itself as a leader in Internet video and has grown traffic through upgrades to its existing pages and the launch of new ones. Although investors have been disappointed with recent results, we believe growing traffic will impact the bottom line over the next year. We therefore reiterate our Buy rating on Yahoo with a six-month target price of $40.00.

Get the full analysis of all four stocks by going to http://at.zacks.com/?id=2649.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2677.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to http://at.zacks.com/?id=2650.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.

(b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUGE
Date:Sep 5, 2006
Words:909
Previous Article:Zacks Analyst Interview Highlights: Anheuser-Busch Companies and Coca-Cola.
Next Article:Warner Home Video Unveils Third American Girl Movie ''Molly: An American Girl on the Home Front'' on DVD November 28; This New, Full-Length,...
Topics:


Related Articles
Zacks Bull and Bear of the Day Highlights: Johnson Controls, King Pharmaceuticals, D. R. Horton and Yahoo!.
Zacks Bull and Bear of the Day Highlights: Linear Technology, Merck & Co., Inc., eBay and Genzyme Corporation.
Zacks Bull and Bear of the Day Highlights: Acusphere, ProQuest Company, Kongzhong and U.S. Steel.
Zacks Bull and Bear of the Day Highlights: AtheroGenics, Endesa-Chile, PPL Corporation and Macerich Company.
Zacks Bull and Bear of the Day Highlights: Zumiez, ProQuest, Myriad Genetics and Prudential.
Zacks Bull and Bear of the Day Highlights: Altera Corp., Kimberly-Clark Corporation, Yahoo! and British Telecom.
Zacks Bull and Bear of the Day Highlights: Critical Therapeutics, Jabil Circuit, SAP A.G. and Duke Realty.
Zacks Bull and Bear of the Day Highlights: Alliant Energy, ProQuest, Snap-on and Trimeris.
Zacks Bull and Bear of the Day Highlights: Linear Technology, Sanmina-SCI, Safeway and Myriad Genetics.
Zacks Bull and Bear of the Day Highlights: Bayer A.G., Chemtura, Zumiez and Kookmin Bank.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters